CSPAX | GEOSX | CSPAX / GEOSX | |
Total Expense Ratio | 1.06 | 0.99 | 107% |
Annual Report Gross Expense Ratio | 1.06 | 1.25 | 85% |
Fund Existence | 24 years | 8 years | - |
Gain YTD | 9.967 | 20.105 | 50% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 80.3B | 26.8M | 299,627% |
Annual Yield % from dividends | 0.58 | 0.00 | - |
Returns for 1 year | 10.28 | 18.50 | 56% |
Returns for 3 years | 25.82 | 5.96 | 433% |
Returns for 5 years | 14.53 | 27.06 | 54% |
Returns for 10 years | 59.78 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VEU | 69.58 | 0.05 | +0.07% |
Vanguard FTSE All-Wld ex-US ETF | |||
MSLC | 52.83 | -0.05 | -0.09% |
Morgan Stanley Pathway Large Cap Eq ETF | |||
EDIV | 39.01 | -0.05 | -0.13% |
SPDR® S&P Emerging Markets Dividend ETF | |||
PBE | 67.68 | -0.13 | -0.19% |
Invesco Biotechnology & Genome ETF | |||
HISF | 44.77 | -0.09 | -0.20% |
First Trust High Income Strat Foc ETF |